A Lower Olfactory Capacity Is Related to Higher Circulating Concentrations of Endocannabinoid 2-Arachidonoylglycerol and Higher Body Mass Index in Women

• Antoni Pastor,

  Affiliations Integrative Pharmacology and Systems Neuroscience Research Group, Neuroscience Research Program, IMIM (Hospital de Mar Medical Research Institute), Barcelona, Spain, Department of Pharmacology, School of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain, CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto Salud Carlos III, Madrid, Spain

  ⨯
• Fernando Fernández-Aranda,

  Affiliations Department of Psychiatry, University Hospital of Bellvitge-IDIBELL, Barcelona, Spain, CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto Salud Carlos III, Madrid, Spain

  ⨯
• Montserrat Fitó,

  Affiliations Cardiovascular Risk and Nutrition Research Group, Inflammatory and Cardiovascular Disorders Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain, CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto Salud Carlos III, Madrid, Spain

  ⨯
• Susana Jiménez-Murcia,

  Affiliations Department of Psychiatry, University Hospital of Bellvitge-IDIBELL, Barcelona, Spain, Department of Clinical Sciences, School of Medicine, University of Barcelona, Barcelona, Spain, CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto Salud Carlos III, Madrid, Spain

  ⨯
• Cristina Botella,

  Affiliations Department of Basic Psychology, Clinic and Psychobiology, University Jaume I, Castelló, Spain, CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto Salud Carlos III, Madrid, Spain

  ⨯
• Jose M. Fernández-Real,

  Affiliations Department of Diabetes, Endocrinology and Nutrition, Institut d’Investigació Biomèdica de Girona (IdlBGi), Hospital Dr Josep Trueta, Girona, Spain, CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto Salud Carlos III, Madrid, Spain

  ⨯
• Gema Frühbeck,

  Affiliations Department of Endocrinology and Nutrition, Clínica Universidad de Navarra, University of Navarra, IdiSNA, Pamplona, Spain, CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto Salud Carlos III, Madrid, Spain

  ⨯
• Francisco J. Tinahones,

  Affiliations Department of Diabetes, Endocrinology and Nutrition, Hospital Clínico Universitario Virgen de Victoria, Málaga, Spain, CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto Salud Carlos III, Madrid, Spain

  ⨯
• Ana B. Fagundo,

  Affiliation Department of Psychiatry, University Hospital of Bellvitge-IDIBELL, Barcelona, Spain

  ⨯
• Joan Rodriguez,

  Affiliation Integrative Pharmacology and Systems Neuroscience Research Group, Neuroscience Research Program, IMIM (Hospital de Mar Medical Research Institute), Barcelona, Spain

  ⨯
• Zaida Agüera,

  Affiliation Department of Psychiatry, University Hospital of Bellvitge-IDIBELL, Barcelona, Spain

  ⨯
• Klaus Langohr,

  Affiliations Integrative Pharmacology and Systems Neuroscience Research Group, Neuroscience Research Program, IMIM (Hospital de Mar Medical Research Institute), Barcelona, Spain, Department of Statistics and Operations Research, Universitat Politècnica de Catalunya, Barcelona, Spain

  ⨯
• Felipe F. Casanueva,

  Affiliations Endocrine Division, Complejo Hospitalario U. de Santiago, Santiago de Compostela University, Santiago de Compostela, Spain, CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto Salud Carlos III, Madrid, Spain

  ⨯
• Rafael de la Torre

  * E-mail: rtorre@imim.es

  Affiliations Integrative Pharmacology and Systems Neuroscience Research Group, Neuroscience Research Program, IMIM (Hospital de Mar Medical Research Institute), Barcelona, Spain, CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto Salud Carlos III, Madrid, Spain, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain

  ⨯